CRP and neoplasm: CRP-MC (Trip) and CRE-NP (α-M) pretreatment or simultaneous administration significantly inhibited tumor growth, and CRP-MC (Trip) and CRE-NP (α-M) pretreatment achieved the strongest anti-tumor effect and completely controlled tumor progression.